The creation of a woolly-mouse embryo marks a significant leap in the field of de-extinction, bringing us one step closer to reviving the iconic woolly mammoth. By combining advanced gene-editing ...
Ablexis’ multi-target licensing agreement grants Almirall rights to use the AlivaMab® Mouse technology for research, development and commercialization of antibodies. AlivaMab Discovery Services will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback